HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


SensiDerm Assay Could Fill Void For Non-Animal Allergy Test In EU

This article was originally published in The Rose Sheet

Executive Summary

U.K-based firm Proteome Sciences eyes the niche for a non-animal sensitivity test. Cosmetics Europe names its SensiDerm assay a first priority for funding.

You may also be interested in...

EU Hopes To Make Animal-Test Ban Global Model

The EU marketing ban on cosmetics containing ingredients tested on animals is in effect, and the European Commission is turning attention to filling gaps in the area of non-animal alternative tests and supporting global efforts to end animal testing for cosmetics.

EU Panel Confirms Animal-Alternative Tests Will Miss 2013 Deadline

A panel of scientific experts says full replacement of animal tests with non-animal alternatives is not possible by the 2013 deadline set under the Seventh Amendment to the European Cosmetics Directive.

Revlon Sees Light Through Bankruptcy Tunnel, Expects to Emerge In April

New York-based Revlon, Inc. expects to emerge from Chapter 11 bankruptcy after a 3 April meeting with the Bankruptcy Court for the Southern District of New York. The firm says it has settled with a group of unsecured creditors and agreed to financial restructuring that should reduce total debt burden by about $2.7bn.

Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts